S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining

References

• Blöcher D, Kunhi M. DNA double-strand break analysis by CHEF electrophoresis. International Journal of Radiation Biology 1990; 58: 23–34
   PubMed Web of Science ®Google Scholar
• Chen M, Hough A M, Lawrence T S. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemotherapy Pharmacology 2000; 45: 369–374
   PubMedGoogle Scholar
• Dewey W C, Wong R S, Albright N. Pulsed-field gel electrophoretic migration of DNA broken by X irradiation during DNA synthesis: Experimental results compared with Monte Carlo calculations. Radiation Research 1997; 148: 413–420
   PubMedGoogle Scholar
• Elliott B, Jasin M. Repair of double-strand breaks by homologous recombination in mismatch repeir-defective mammalian cells. Molecular and Cellular Biology 2001; 21: 2671–2682
   PubMedGoogle Scholar
• Ewald B, Sampath D, Plunkett W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Molecular Cancer Therapeutics 2007; 6: 1239–1248
   PubMed Web of Science ®Google Scholar
• Flanagan S A, Robinson B W, Krokosky C M, Shewach D S. Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: A new paradigm for antimetabolite radiosensitizers. Molecular Cancer Therapeutics 2007; 6: 1858–1868
   PubMed Web of Science ®Google Scholar
• Flentje M, Asadpour B, Latz D, Weber K J. Sensitivity of neutral filter elution but not PFGE can be modified by non-DSB chromatin damage. International Journal of Radiation Biology 1993; 63: 715–724
   PubMed Web of Science ®Google Scholar
• Gauter B, Zlobiskaya O, Weber K J. Rejoining of radiation-induced DNA double-strand breaks: Pulsed-field electrophoresis analysis of fragment size distributions after incubation for repair. Radiation Research 2002; 157: 721–733
   PubMed Web of Science ®Google Scholar
• Grégoire V, Beauduin M, Rosier J-F, Bruniaux M, De Coster B, Octave-Prignot M, Scalliet P. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis. International Journal of Radiation Biology 1998; 73: 511–520
   PubMedGoogle Scholar
• Grégoire V, Hittelmann W N, Rosier J F, Milas L. Chemo-radiotherapy: Radiosenitizing nucleoside analogues (review). Oncology Reports 1999; 6: 949–957
   PubMedGoogle Scholar
• Huang P, Chubb S, Hertel L W, Grindey G B, Plunkett W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Research 1991; 51: 6110–6117
   PubMed Web of Science ®Google Scholar
• Iliakis G E, Cicilioni O, Metzger L. Measurement of DNA double-strand breaks in CHO cells at various stages of the cell cycle using pulsed field gel electrophoresis: calibration by means of 125I decay. International Journal of Radiation Biology 1991; 59: 343–357
   PubMed Web of Science ®Google Scholar
• Jeggo P A. Identification of genes involved in repair of DNA double strand breaks in mammalian cells. Radiation Research 1998; 150: S80–91
   PubMed Web of Science ®Google Scholar
• Jiricny J. The multifaceted mismatch-repair system. Nature Reviews Molecular Cell Biology 2006; 7: 335–346
   PubMed Web of Science ®Google Scholar
• Kanaar R, Hoejmakers J H, van Gent D C. Molecular mechanisms of DNA double strand break repair. Trends in Cell Biology 1998; 8: 483–489
   PubMed Web of Science ®Google Scholar
• Latz D, Dewey W C, Flentje M, Lohr F, Wenz F, Weber K J. Migration patterns in pulsed-field electrophoresis of DNA restriction fragments from log-phase mammalian cells after irradiation and incubation for repair. International Journal of Radiation Biology 1996; 70: 637–646
   PubMed Web of Science ®Google Scholar
• Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber K J. Radiosensitizing potential of Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine) within the cell cycle in vitro. Intenational Journal of Radiation Oncology Biology Physics 1998; 41: 875–882
   PubMed Web of Science ®Google Scholar
• Lawrence T S, Eisbruch A, McGinn C J, Fields M T, Shewach D S. Radiosensitization by gemcitabine. Oncology 1999; 13: 55–60
   PubMedGoogle Scholar
• Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annual Reviews in Biochemistry 1996; 65: 101–133
   PubMed Web of Science ®Google Scholar
• Mose S, Karapetian M, Jüling-Pohlit L, Taborski B, Damrau M, Ramm U, Rahn A, Böttcher H D. Radiation enhancement of Gemcitabine in two human squamous cell carcinoma cell lines. Anticancer Research 2000; 20: 401–406
   PubMed Web of Science ®Google Scholar
• Ostruszka L, Shewach D S. The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Research 2000; 60: 6080–6088
   PubMedGoogle Scholar
• Plunkett W, Huang P, Xu Y, Grunewald R, Gandhi V. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Seminars in Oncology 1995; 22: 3–10
   PubMed Web of Science ®Google Scholar
• Robinson B W, Im M M, Ljungman M, Praz F, Shewach D S. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. Cancer Research 2003; 63: 6935–6941
   PubMed Web of Science ®Google Scholar
• Robinson B W, Ostruszka L, Im M M, Shewach D S. Promising combination therapies with gemcitabine. Seminars in Oncology 2004; 31: 2–12
   PubMedGoogle Scholar
• Rosier J-F, Michaux L, Ameye G, Cedervall B, Libouton J-M, Octave-Prignot M, Verellen-Dumoulin C, Scalliet P, Gregoire V. The radioenhancement of two human head and neck squamous cell carcinomas by 2′,2′-difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutation Research 2003; 527: 15–26
   PubMedGoogle Scholar
• Rothkamm K, Krüger I, Thomson L H, Löbrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Molecular and Cellular Biology 2003; 23: 5706–5715
   PubMed Web of Science ®Google Scholar
• Shewach D S, Hahn T M, Chang E, Hertel L W, Lawrence T S. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Research 1994; 54: 3218–3223
   PubMed Web of Science ®Google Scholar
• Toschi L, Finochiaro G, Bartolini S, Gioia V, Capuzzo F. Role of gemcitabine in cancer therapy. Future Oncology 2005; 1: 7–17
   PubMedGoogle Scholar
• Van Bree C, Rodermond H M, de Vos J, Haveman J, Franken N AP. Mismatch repair proficiency is not required for radioenhancement by gemcitabine. International Journal of Radiation Oncology Biology Physics 2005; 62: 1504–1509
   PubMedGoogle Scholar
• Van Moorsel C J, Smid K, Voorn D A, Bergmann A M, Pinedo H M, Peters G J. Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxynucleotide pools in ovarian cancer cell lines. International Journal of Oncology 2003; 22: 201–207
   PubMed Web of Science ®Google Scholar
• Van Putten J WG, Groen H JM, Smid K, Peters G J, Kampinga H H. End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Research 2001; 61: 1585–1591
   PubMedGoogle Scholar
• Wachters F M, Van Putten J WG, Maring J G, Zdziencka M Z, Groen H JM, Kampinga H H. Selective targeting of homologous DNA recombination repair by gemcitabine. International Journal of Radiation Oncology Biology Physics 2003; 57: 553–562
   PubMed Web of Science ®Google Scholar
• Weiss C, Grabenbauer G G, Sauer R, Distel L. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine. Strahlentherapie und Onkologie 2003; 179: 93–98
   PubMedGoogle Scholar
• Wheeler J MD, Beck N E, Kim H C, Tomlinson I PM, Mortensen NJMcC, Bodmer W F. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer celllines: The predominant role of hMLH1. Proceedings of the National Academy of Sciences USA 1999; 96: 10296–10301
   PubMedGoogle Scholar